Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara

Ruchika Sharma1 Dec 2022 1:15 PM IST

If Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.

USFDA approves first Fecal Microbiota product REBYOTA from Ferring Pharma

Ruchika Sharma1 Dec 2022 12:15 PM IST

REBYOTA is a pre-packaged, single-dose 150 mL microbiota suspension for rectal administration.

USFDA nod to Zydus Lifesciences Migraine drug Topiramate Extended Release

Ruchika Sharma1 Dec 2022 11:16 AM IST

The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.

USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid

Britain regulator calls for review of reactions in eyes to Sanofi asthma drug Dupixent

Ruchika Sharma30 Nov 2022 5:30 PM IST

European and U.S. health regulators have listed conjunctivitis, an eye irritation that can cause redness and discomfort, as a side effect of Dupixent

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Gland Pharma Singapore arm to acquire Cenexi Group for over Rs 1000 crore

Ruchika Sharma30 Nov 2022 4:30 PM IST

The acquisition provides Gland Pharma access to leading know-how and development capabilities in sterile forms including for ophthalmic gel,...

JB Pharma bags USFDA nod for Major Depressive Disorder drug Venlafaxine Extended Release

Ruchika Sharma30 Nov 2022 3:30 PM IST

A selective serotonin and norepinephrine reuptake inhibitor (SNRI), Venlafaxine Extended-Release tablets are indicated for Major Depressive Disorder...

Boston Scientific to acquire Medical Technology firm Apollo Endosurgery

Ruchika Sharma30 Nov 2022 2:30 PM IST

"Boston Scientific expects to complete the transaction in the first half of 2023, subject to satisfaction of customary closing conditions.

Fosun Pharma said to mull sale of USD 3.6 billion Gland Pharma

Ruchika Sharma30 Nov 2022 1:30 PM IST

Fosun Pharma acquired a 74 percent stake in Gland for about $1.1 billion in 2017 from an investor group including KKR & Co.

Need separate ministry for pharma sector, opines Industry CEOs

Ruchika Sharma30 Nov 2022 12:15 PM IST

The leaders also pointed out the need to reduce dependency on China by using technology.

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Viatris sells global biosimilars business to Biocon Biologics for USD 3 billion

Ruchika Sharma30 Nov 2022 11:23 AM IST

The acquisition provides Biocon Biologics with direct commercial capabilities and supporting infrastructure in the advanced markets and several...

Zydus Lifesciences appoints Akhil Monappa, Upasana Kamineni Konidela as new Independent Directors

Ruchika Sharma29 Nov 2022 4:17 PM IST

Ahmedabad: Zydus Lifesciences has announced the appointment of Akhil Monappa and Upasana Kamineni Konidela as the Independent Directors of the Company...

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche Pharma India launches new digital platform - The Blue Tree 2.0 mobile app

Ruchika Sharma29 Nov 2022 3:35 PM IST

Roche Pharma India partnered with smart tech solutions provider MOURI Tech to develop this patient-centric mobile app.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok